Safia studied biology at UCL and she followed that up with a PhD looking at how cancer cells respond to chemotherapy. Her first three years at CRUK were with the science communications team but she’s since moved to research funding where she’s looking for ways to boost research into cancers of the pancreas, lung, oesophagus and brain.
As we launch our new strategy, we catch up with chief scientist, Professor Nic Jones, and get his take on our plans for the future.
We welcome the latest group of scientists who’ve just been awarded funding from Cancer Research UK.
In our previous post in this series, we talked about how the tumour microenvironment helps tumour cells leave a primary…
No man is an island, and the same can be said of tumour cells. Previous posts in our ‘microenvironment’ series…
We now know that inflammation’s dark side is a powerful force in cancer development, where it aids and abets tumour growth and spread around the body.
Biology has its share of contentious issues, and the existence of cancer ‘stem cells’ – treatment-resistant cells at the heart…
Professor Phil Ingham’s research in fruit flies and fish evolved into a drug to treat patients with advanced basal cell carcinoma, a type of skin cancer.
Dr Gareth Veal wants to improve the way we treat children with cancer, so that every child receives a dose of chemotherapy that is “just right”.
Being told your child has cancer is every parent’s worst nightmare. But every year, around 1500 families are given this…
No man is an island – we exist together with other people in families, communities and societies. The same is…